newsfilter
← Latest News
Business Wire·

U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat

  • Turn Therapeutics Inc. (NASDAQ: TTRX) will host a U.S. Bancorp | BTIG virtual fireside chat on Wednesday, October 28, 2026, at 10:00 AM ET.
  • CEO Bradley Burnam & Executive Clinical & Regulatory Lead Stephen M. Hahn, M.D., will lead the discussion.
  • The event titled "Building a Program for Patient Access in Atopic Dermatitis" will focus on GX-03, the company's lead investigational therapy for atopic dermatitis & onychomycosis.
  • The presentation outlines the company's strategy to increase access to effective medicines for high-need populations through targeted, non-systemic therapies.
  • Attendance is restricted to U.S. Bancorp | BTIG institutional clients who must contact a BTIG sales representative to join.
  • Turn Therapeutics researches the intersection of microbial activity, local immune signaling, & chronic inflammation.